Stock Events

Stock Events

biote 

$2.19
15
-$0.06-2.67% Tuesday 20:00

Statistics

Day High
2.28
Day Low
2.12
52W High
4.75
52W Low
1.27
Volume
198,477
Avg. Volume
-
Mkt Cap
70.67M
P/E Ratio
5.23
Dividend Yield
-
Dividend
-

Upcoming

Earnings

6AugExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
0.02
0.14
0.25
0.37
Expected EPS
0.0225
Actual EPS
N/A

Financials

1.6%Profit Margin
Profitable
2021
2022
2023
2024
394.38MRevenue
6.31MNet Income

Analyst Ratings

2.83Average Price Target
The highest estimate is 4.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
67%
Hold
33%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BTMD. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbvie
ABBV
Mkt Cap402.35B
AbbVie operates in the hormone replacement therapy market, directly competing with Biote's bioidentical hormone replacement therapy offerings.
Pfizer
PFE
Mkt Cap149.38B
Pfizer has a broad portfolio in healthcare, including hormone therapy products that compete with Biote's solutions.
AMGEN
AMGN
Mkt Cap191.7B
Amgen focuses on innovative biotechnologies and medical solutions that overlap with Biote's hormone therapy treatments.
Gilead Sciences
GILD
Mkt Cap155.93B
Gilead Sciences, known for its biopharmaceutical products, competes in the same biotech and healthcare sectors as Biote.
Merck
MRK
Mkt Cap294.03B
Merck operates in various healthcare segments, including hormone-related therapies, making it a competitor to Biote.
Bristol-Myers Squibb
BMY
Mkt Cap116.66B
Bristol Myers Squibb's diverse pharmaceutical products place it in direct competition with Biote, especially in the biotech-driven therapy space.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap40.32B
Teva Pharmaceutical Industries specializes in generic and specialty medicines, including hormone therapies that compete with Biote's offerings.
Novo Nordisk
NVO
Mkt Cap194.35B
Novo Nordisk's focus on hormone replacement therapies, particularly in the diabetes and obesity areas, positions it as a competitor to Biote.
Regeneron Pharmaceuticals
REGN
Mkt Cap64.18B
Regeneron Pharmaceuticals is involved in biopharmaceuticals that target various medical conditions, competing with Biote in the broader biotech healthcare market.

About

Biote Corp. is dedicated to supporting and developing medical practices that focus on hormone optimization. The company provides a comprehensive system for its Biote-certified healthcare professionals, enabling them to correct imbalances in patients' hormone, vitamin, and mineral levels. This includes authorizing the prescription of bioidentical hormone treatments and suggesting suitable dietary supplements. Furthermore, Biote offers its own line of branded nutritional supplements and supplies sterile kits for inserting hormone pellets for both male and female individuals. Founded in 2011, Biote Corp. is based in Irvine, Texas.
Show more...
CEO
Mr. Bret Christensen
Employees
217
Country
United States
ISIN
US0906831039

Listings

XNAS
US
BTMD
BOATS
BOATS
BTMD.BOATS

0 Comments

Share your thoughts

FAQ

What is biote stock price today?▼
The current price of BTMD is $2.19 USD — it has decreased by -2.67% in the past 24 hours. Watch biote stock price performance more closely on the chart.
What is biote stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange biote stocks are traded under the ticker BTMD.
Is biote stock price growing?▼
BTMD stock has fallen by -3.52% compared to the previous week, the month change is a +11.17% rise, over the last year biote has showed a -44.27% decrease.
What is biote market cap?▼
Today biote has the market capitalization of 70.67M
When is the next biote earnings date?▼
biote is going to release the next earnings report on August 06, 2026.
What were biote earnings last quarter?▼
BTMD earnings for the last quarter are 0.06 USD per share, whereas the estimation was 0.05 USD resulting in a +26.32% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is biote revenue for the last year?▼
biote revenue for the last year amounts to 394.38M USD.
What is biote net income for the last year?▼
BTMD net income for the last year is 6.31M USD.
How many employees does biote have?▼
As of June 17, 2026, the company has 217 employees.
In which sector is biote located?▼
biote operates in the Health & Wellness sector.
When did biote complete a stock split?▼
The last stock split for biote was on June 01, 2007 with a ratio of 1:10.
Where is biote headquartered?▼
biote is headquartered in Irving, United States.